Function expands into imaging and genomics

Diving deeper into

Function Health at $100M/year

Document
now expanding into imaging and genomics as it builds a unified platform for self-directed health tracking.
Analyzed 6 sources

Function is trying to turn a one time lab purchase into a durable personal health record. Blood tests bring members in every 6 to 12 months, but imaging and genomics add higher value data that can live beside labs in one account, make the product feel more comprehensive, and create more reasons to stay subscribed instead of treating testing like a one off transaction.

  • Imaging is already becoming a real product line, not just a future idea. After acquiring Ezra in May 2025, Function added $499 full body MRI scans, down from Ezra’s prior $1,495 price, and is working to pull those scan results into the same Function account as lab results.
  • The practical reason to add imaging is that blood and scans catch different things. Function describes MRI and CT as a way to spot issues like fatty liver, aneurysms, structural brain changes, and coronary calcium that may not show up in labs alone, while blood based tests like GRAIL add another detection layer.
  • The strategic race is toward a single consumer health dashboard fed by many data types. Oura is moving from wearables into Quest based lab panels, while Superpower already bundles labs, genetic testing, and other add on diagnostics into one workflow. Function is taking the same convergence path from the blood testing side.

The next step is a normalized consumer health record that combines repeat labs, scans, wearables, and eventually genomic risk into one longitudinal timeline. If Function executes, it can become the front end where people check their numbers, compare changes over time, and buy the next test, instead of being just another lab reseller.